
Opinion|Videos|October 18, 2024
When Is the Right Time? Navigating Key Moments for Referring Multiple Myeloma Patients to an Academic Center
Panelists discuss how the initial process of identifying and referring potential candidates for bispecific therapy from the community setting to an academic center involves careful patient assessment, clear communication channels, and established referral protocols to ensure timely and appropriate treatment initiation.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- Could you describe the initial process of identifying and referring potential candidates for bispecific therapy from the community setting to an academic center?
Advertisement
Related to this article
Advertisement
Advertisement
Trending on CancerNetwork
1
Key Takeaways for Multidisciplinary Lung Cancer Care From WCLC 2026
2
CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma
3
FDA Approves Imlunestrant Combo in ESR1-Mutated Breast Cancer
4
Pembrolizumab/Enfortumab Vedotin Earns Positive CHMP Opinion in MIBC
5


